Related references
Note: Only part of the references are listed.The effect of different dosing regimens of levodopa/carbidopa/entacapone on plasma levodopa concentrations
Kimmo Ingman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone
Heinz Reichmann et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Night-time bioavailability of levodopa/carbidopa/entacapone is higher compared to controlled-release levodopa/carbidopa
M. Kuoppamäki et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Inhibition of catechol-O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson's disease
Thomas Mueller et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
Angelo Antonini
Neuropsychiatric Disease and Treatment (2011)
Sustained-release Madopar HBS® compared with standard Madopar® in the long-term treatment of de novo parkinsonian patients
E. Dupont et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease The STRIDE-PD Study
Fabrizio Stocchi et al.
ANNALS OF NEUROLOGY (2010)
Pharmacokinetics of levodopa
Manuela Contin et al.
JOURNAL OF NEUROLOGY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
The Concept of Continuous Dopaminergic Stimulation: What We Should Consider when Starting Parkinson's Disease Treatment
Fabrizio Stocchi
NEURODEGENERATIVE DISEASES (2010)
Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily
Mikko Kuoppamaki et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Adherence to Antiparkinson Medication in a Multicenter European Study
Donald Grosset et al.
MOVEMENT DISORDERS (2009)
Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion
Birgit Meiler et al.
MOVEMENT DISORDERS (2008)
Comparison of 200 mg retarded release levodopa/carbidopa -: with 150 mg levodopa/carbidopa/entacapone application:: pharmacokinetics and efficacy in patients with Parkinson's disease
T. Mueller et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Relating mode of action to clinical practice: Dopaminergic agents in Parkinson's disease
Peter Riederer et al.
PARKINSONISM & RELATED DISORDERS (2007)
Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson's disease
T. Mueller et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels
T Müller et al.
MOVEMENT DISORDERS (2006)
Pharmacokinetic optimisation in the treatment of Parkinson's disease - An update
D Nyholm
CLINICAL PHARMACOKINETICS (2006)
Levodopa, motor fluctuations and dyskinesia in Parkinson's disease
Thomas Mueller et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study
DJ Brooks et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Optimizing levodopa phannacokinetics:: Intestinal infusion versus oral sustained-release tablets
D Nyholm et al.
CLINICAL NEUROPHARMACOLOGY (2003)
Nonmotor fluctuations in Parkinson's disease -: Frequent and disabling
T Witjas et al.
NEUROLOGY (2002)
Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study)
WH Poewe et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
JE Ahlskog et al.
MOVEMENT DISORDERS (2001)
Share Paper
